RMF-003

RMF-003 is a preclinical regenerative medical formulation developed by Cellontech, a South Korean biotechnology company specializing in tissue engineering and regenerative medicine. It is a collagen-based biomaterial, specifically utilizing atelocollagen, which is collagen processed to remove immunogenic telopeptides while maintaining its structural integrity. RMF-003 is designed to serve as a biocompatible scaffold to facilitate tissue repair and regeneration, primarily targeting soft tissue injuries such as tendon and ligament damage. The formulation provides a microenvironment conducive to cell adhesion, migration, and proliferation, supporting the body's natural healing processes by mimicking the extracellular matrix. As part of Cellontech's Regenerative Medical Formulation (RMF) series, it represents a non-cell-based approach to tissue repair, complementing their cell-based Regenerative Medical System (RMS) products.

Other names

Regenerative Medical Formulation 003Cellontech atelocollagen formulation